Changes of serum Clq/TNF-Related Protein2 levels and its association with insulin resistance in population with different glucose tolerances

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031727

Enrollment

Unknown

Registered

2020-04-08

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes and impaired glucose tolerance

Interventions

NGT group, IGT group and T2DM group:N/A

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients whose blood glucose (blood glucose at any time in one day) was >= 11.1 mmol / L (200 mg / dl) were randomized; 2. Patients with fasting blood glucose (fasting state refers to at least 8 hours without any calorie intake) >= 7.0mmol/l (126 mg / dl); 3. Patients with OGTT 2 h blood glucose >= 11.1 mmol / L (200 mg / dl).

Exclusion criteria

Exclusion criteria: 1. Patients with ketoacidosis, macrovascular or microvascular complications; 2. Patients with hypertension; 3. Patients with liver and kidney failure and cirrhosis; 4. Patients with congestive heart failure and other major diseases.

Design outcomes

Primary

Measure	Time frame
Glu;	—

Countries

China

Contacts

Public ContactLiu Zhangling

Shapingba District People's Hospital of Chongqing

liuling20071@163.com+86 13658370631

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026